RCN3 and cutaneous melanoma: As shown in Figures 2A–I, RCN3 expression varied significantly in different pathological stages of cancers, including ACC (adrenocortical carcinoma), BLCA (bladder urothelial carcinoma), BRCA, COAD, ESCA, HNSC, READ (rectum adenocarcinoma), SKCM (skin cutaneous melanoma), and THCA (thyroid carcinoma).